Analogic Corporation Receives TSA Order for Five COBRA Checkpoint Explosives and Weapons Detection Systems

PEABODY, MASS. (September 26, 2006) – Analogic Corporation (NASDAQ: ALOG) announced today that the U.S. Transportation Security Administration (TSA) has placed an order for five COBRA™ Computed Tomography (CT) based explosives and weapons detection systems, four of which are to be deployed at airport checkpoints in early 2007 for testing and evaluation. The $3.8-million order includes installation and onsite support provided by Analogic.

Analogic’s COBRA system, initiated independently by the Company, was enhanced under a TSA contract as part of its CAMBRIA program to develop a new generation of automatic threat-detection checkpoint security systems. This TSA order for multiple COBRA systems is part of TSA’s plan to accelerate development of the COBRA for future deployment into checkpoints.

Scanning approximately 400 bags or bins per hour, the COBRA provides high-resolution 3-D images of the contents of a bag or bin, which can be rotated on-screen with the touch of a finger. The system automatically detects explosives, weapons, and other potential threats, and highlights these for closer inspection by the operator. Laptop computers can be scanned in their cases, and an automatic bin return system saves additional time and labor, returning empty bins beneath the system on a motorized conveyor.

John Wood, Analogic’s President and CEO, said, “The deployment of our COBRA systems is an important step forward for Analogic. Screening items at the checkpoint using advanced CT technology is a natural progression for us and an important step in better securing our nation’s airports. The COBRA will provide significantly enhanced detection capabilities and do so faster with unsurpassed imaging capabilities.”

Analogic Corporation is a leading designer and manufacturer of advanced health and security systems and subsystems sold primarily to Original Equipment Manufacturers (OEMs). The Company is recognized worldwide for advancing the state of the art in Computed Tomography (CT), Digital Radiography (DR), Ultrasound, Magnetic Resonance Imaging (MRI), and Patient Monitoring.

Forward-Looking Statements

Any statements in this press release about future expectations, plans, and prospects for the Company, including statements about orders for the Company’s products, statements about shipments and installation of the Company’s products, and other statements containing the words “believes,” “anticipates,” “plans,” “expects,” and similar expressions, constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including risks relating to technology development and commercialization, risks in product development, limited demand for the Company’s products, risks associated with competition, uncertainties associated with regulatory agency approvals, competitive pricing pressures, downturns in the economy, the risk of potential intellectual property litigation, and other factors discussed in our most recent quarterly report filed with the Securities and Exchange Commission. In addition, the forward-looking statements included in this press release represent the Company’s views as of September 26, 2006. The Company anticipates that subsequent events and developments will cause the Company’s views to change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company’s views as of any date subsequent to September 26, 2006.